Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Communication × Clear all

Phase

Phase NA 60 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1626 Carcinoma, Non-Small-Cell Lung 1142 Prostatic Neoplasms 861 Colorectal Neoplasms 726 Multiple Myeloma 633 Leukemia, Myeloid, Acute 611 Lung Neoplasms 584 Neoplasms 580 Neoplasm Metastasis 549 Lymphoma 493 Pancreatic Neoplasms 490 Carcinoma, Hepatocellular 481 Stomach Neoplasms 450 Leukemia 446 Recurrence 429 Melanoma 388 Leukemia, Lymphocytic, Chronic, B-Cell 381 Precursor Cell Lymphoblastic Leukemia-Lymphoma 380 Ovarian Neoplasms 372 Lymphoma, Non-Hodgkin 369 Squamous Cell Carcinoma of Head and Neck 359 Myelodysplastic Syndromes 358 Lymphoma, Large B-Cell, Diffuse 354 Head and Neck Neoplasms 351 Brain Neoplasms 348 Rectal Neoplasms 338 Glioblastoma 332 Carcinoma, Renal Cell 299 Esophageal Neoplasms 289 Hodgkin Disease 288

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04642677 2021-11-02

RESTORE

Pusan National University Yangsan Hospital

Phase 2 Unknown

Communication

Data powered by HemOnc (CC BY 4.0) Colophon ⚡